Modifi

Healthcare

Merck Takes on Brain Cancer With Acquisition of Yale Spinoff Modifi

Photo by JHVEPhoto via iStock

Modifi Biosciences announced that it has been acquired by global pharmaceutical giant Merck, with a $30 million down payment.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.